Internal Medicine, Hematology & Oncology · New York, NY
NPI
1396866034
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
177 Fort Washington Ave, Mhb 6gn-435, New York-Presbyterian/Columbia
New York, NY, 10032
Phone (212) 305-0983
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
546 services
Medicare patients, 2024
134
Average age 74
Drug cost, 2024
$2.9M
681 prescriptions
Company payments, 2025
$14K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Changchun Deng was code 99214 (office e&m - established), 140 times for 70 patients. In total Changchun Deng billed 546 services in 17 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-11-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 140 | 70 | $68.68 | $9,615 |
| 99215 Office E&M - Established | Facility | 131 | 47 | $104.57 | $14K |
| 99233 Hospital E&M - Subsequent | Facility | 113 | 26 | $89.61 | $10K |
| 99232 Hospital E&M - Subsequent | Facility | 62 | 21 | $59.52 | $3,690 |
| 99213 Office E&M - Established | Facility | 31 | 27 | $45.07 | $1,397 |
| 99223 Hospital E&M - Initial | Facility | 17 | 16 | $130.52 | $2,219 |
| 99238 Hospital Discharge Management | Facility | 12 | 12 | $60.88 | $731 |
| 99204 Office E&M - New | Facility | 11 | 11 | $91.84 | $1,010 |
By year: 2023 $26K for 287 services; 2024 $45K for 546 services.
Medicare prescription drug claims, 2024
In 2024, the drug Changchun Deng prescribed most often to Medicare patients was Brukinsa (Zanubrutinib), with 138 prescriptions and refills. In total Changchun Deng wrote 681 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Brukinsa Zanubrutinib | 138 | 138 | 21 | $2.1M |
| Acyclovir Generic | 103 | 134 | 31 | $826 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 62 | 68 | 22 | $200 |
| Prednisone Generic | 53 | 53 | 24 | $104 |
| Allopurinol Generic | 35 | 41 | 18 | $74.94 |
| Prochlorperazine Maleate Generic | 33 | 33 | 27 | $308 |
| Ondansetron Hcl Generic | 31 | 31 | 25 | $526 |
| Imbruvica Ibrutinib | 21 | 21 | Under 11 | $339K |
| Dexamethasone Generic | 19 | 19 | Under 11 | $148 |
| Venclexta Venetoclax | 18 | 18 | Under 11 | $280K |
| Eliquis Apixaban | 17 | 23 | Under 11 | $14K |
| Gabapentin Generic | 16 | 20 | Under 11 | $306 |
| Olanzapine Generic | 12 | 12 | Under 11 | $52.86 |
| Atorvastatin Calcium Generic | 11 | 17 | Under 11 | $14.29 |
Brand drugs: 215 claims; generic drugs: 466 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Changchun Deng $14K ($14K in general payments such as food, travel and fees) from 17 companies. The largest payer was BeOne Medicines USA, Inc. with $9,343.
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. ONC | 5 | $9,343 |
| Incyte Corporation INCY | 2 | $1,678 |
| Merck Sharp & Dohme LLC MRK | 9 | $1,453 |
| Deciphera Pharmaceuticals Inc. | 1 | $620 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $306 |
| Taiho Oncology, Inc. 4578.T | 4 | $203 |
| Janssen Research & Development, LLC JNJ | 1 | $146 |
| Lilly USA, LLC LLY | 1 | $101 |
| Kite Pharma, Inc. GILD | 1 | $21.28 |
| Genentech USA, Inc. ROG.SW | 1 | $19.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.